Kangmei Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.00%

Kangmei Pharmaceutical Co Ltd (600518) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥91.40K

≈ $13.37K USD Cash + Short-term Investments

Total Assets

CN¥13.68 Billion

≈ $2.00 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Kangmei Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Kangmei Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Kangmei Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Kangmei Pharmaceutical Co Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥91.40K	0.0%
Total Liquid Assets	CN¥91.40K	0.00%

Asset Resilience Insights

Limited Liquidity: Kangmei Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Kangmei Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Kangmei Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	1.95%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	11.00%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%

Annual Asset Resilience Ratio for Kangmei Pharmaceutical Co Ltd (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Kangmei Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.00%	CN¥80.96K ≈ $11.85K	CN¥13.80 Billion ≈ $2.02 Billion	+0.00pp
2023-12-31	0.00%	CN¥82.80K ≈ $12.12K	CN¥14.28 Billion ≈ $2.09 Billion	0.00pp
2022-12-31	0.00%	CN¥117.31K ≈ $17.17K	CN¥15.11 Billion ≈ $2.21 Billion	0.00pp
2021-12-31	0.00%	CN¥524.30K ≈ $76.72K	CN¥16.05 Billion ≈ $2.35 Billion	-0.01pp
2019-12-31	0.01%	CN¥5.88 Million ≈ $860.14K	CN¥64.59 Billion ≈ $9.45 Billion	--

pp = percentage points

About Kangmei Pharmaceutical Co Ltd

SHG:600518 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.69 Billion

CN¥18.39 Billion CNY

Market Cap Rank

#5154 Global

#869 in China

Share Price

CN¥1.33

Change (1 day)

-2.92%

52-Week Range

CN¥1.20 - CN¥2.20

All Time High

CN¥27.48